Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/16/2021 | $16.00 → $13.00 | Buy | Chardan Capital |
| 10/19/2021 | $28.00 → $16.00 | Buy | Chardan Capital |
| 10/18/2021 | $20.00 → $10.00 | Buy | HC Wainwright & Co. |
Chardan Capital reiterated coverage of BiomX with a rating of Buy and set a new price target of $13.00 from $16.00 previously
Chardan Capital reiterated coverage of BiomX with a rating of Buy and set a new price target of $16.00 from $28.00 previously
HC Wainwright & Co. reiterated coverage of BiomX with a rating of Buy and set a new price target of $10.00 from $20.00 previously
4 - BiomX Inc. (0001739174) (Issuer)
4/A - BiomX Inc. (0001739174) (Issuer)
4/A - BiomX Inc. (0001739174) (Issuer)
8-K - BiomX Inc. (0001739174) (Filer)
SCHEDULE 13G/A - BiomX Inc. (0001739174) (Subject)
SCHEDULE 13G - BiomX Inc. (0001739174) (Subject)